ICCC

IMMUCELL CORP

Latest Form 4:Purchase$76Kbyte Boekhorst Paul Francis Olivier (President and CEO) · filed Jun 22, 2026

IMMUCELL CORP (ICCC) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 22, 2026.

The most active filer is President and CEO te Boekhorst Paul Francis Olivier with 3 filings.

  • Industry:Biotechnology
  • CEO:F. Olivier Te Boekhorst
  • Employees:69
  • HQ:Portland, ME, US
  • IPO:1987-05-05

Insider Buying

$107K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$90.9M

latest known value

Source
Purchase$76KJun 22SEC ↗
Purchase$18KDec 4SEC ↗
Purchase$13KDec 4SEC ↗

Related companies

IMMUCELL CORP is in the Healthcare sector.